What is Beijing Strong Biotechnologies Revenue per Share?
Beijing Strong Biotechnologies's revenue per share for the
three
months ended in Mar. 2024 was ¥0.69.
Beijing Strong Biotechnologies's revenue per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2.97.
During the past 12 months, the average Revenue Per Share Growth Rate of Beijing Strong Biotechnologies was 14.40% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was 22.60% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was 16.40% per year.
During the past 10 years, the average Revenue Per Share Growth Rate was 5.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for Beijing Strong Biotechnologies's Revenue per Share or its related term are showing as below:
SZSE:300406'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -16.9 Med: 11.95 Max: 53.2
Current: 22.6
During the past 13 years, Beijing Strong Biotechnologies's highest 3-Year average Revenue Per Share Growth Rate was 53.20% per year. The lowest was -16.90% per year. And the median was 11.95% per year.
SZSE:300406's 3-Year Revenue Growth Rate is ranked better than 80% of 200
companies
in the Medical Diagnostics & Research industry
Industry Median: 6.4
vs SZSE:300406: 22.60
Beijing Strong Biotechnologies Revenue per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Beijing Strong Biotechnologies Revenue per Share Chart
Competitive Comparison of Beijing Strong Biotechnologies's Revenue per Share
For the Diagnostics & Research subindustry, Beijing Strong Biotechnologies's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beijing Strong Biotechnologies's PS Ratio Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Beijing Strong Biotechnologies's PS Ratio distribution charts can be found below:
* The bar in red indicates where Beijing Strong Biotechnologies's PS Ratio falls into.
Beijing Strong Biotechnologies Revenue per Share Calculation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2.97
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Strong Biotechnologies (SZSE:300406) Revenue per Share Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Beijing Strong Biotechnologies Revenue per Share Related Terms
Thank you for viewing the detailed overview of Beijing Strong Biotechnologies's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Beijing Strong Biotechnologies (SZSE:300406) Business Description
Beijing Strong Biotechnologies Inc is a China-based provider of in-vitro (IVD) diagnostics products and service. The company is engaged in the research, development, production, and sale of IVD products. It also provides diversified clinical diagnosis solutions to customers. Its products include clinical biochemistry testing, coagulation testing, blood typing, serology and automated blood grouping analyzer. The firm has established a clinical biochemistry platform of the enzymatic method (including enzymatic cycling method), immunoturbidimetric method, and latex immunoturbidimetric method.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:300406 has been successfully added to your 